TIANYIN PHARMACEUTICAL CO., INC.
DelistedCIK 1362718fmd_07GEBFKY9H4M5Q9QDZPTDQ60YXManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jul 01, 2010 to Mar 31, 2015, 19 periods
| Line item | FY2011 | FY2012 | FY2013 | FY2014 |
|---|---|---|---|---|
| Total revenues | 95 | 70 | 68 | 47 |
| Cost of revenue | 53 | 45 | 41 | 31 |
| Gross profit | 43 | 24 | 26 | 16 |
| Research and development | 1 | 1 | 1 | 1 |
| Total operating expenses | 24 | 16 | 17 | 13 |
| Operating income | 18 | 9 | 9 | 3 |
| Interest expense | 0 | 0 | 0 | 0 |
| Interest and investment income | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | 2 | 0 | (0) | (3) |
| Income before taxes | 20 | 9 | 9 | (1) |
| Income tax expense | 4 | 2 | 2 | 0 |
| Net income from continuing operations | 16 | 6 | 7 | (1) |
| Net income | 16 | 6 | 7 | (1) |
| Net income to common shareholders | 16 | 6 | 7 | – |